Middle East and Africa Clinical Trials Supplies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product & Service (Manufacturing, Packaging & Labelling, and Logistics & Distribution), Stage (Phase I, Phase II, Phase III, and Bioequivalence Studies), Drug Type (Small-Molecule Drugs and Biologic Drugs), and Application (Oncology, Cardiovascular Diseases, Neurological Disorders, Respiratory Disorders, and Others)

Code: TIPRE00022072 | Pages: 127 | Industry: Pharmaceuticals | Date: May 2021 | Type: Regional

Market Introduction

The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human applications. These studies help to find which therapeutic approaches experiment is best for certain diseases. Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance.

 


Get more information on this report :



Market Overview and Dynamics

The Middle East and Africa clinical trial supplies market is expected to reach US$ 96.33 Mn by 2027 from US$ 60.93 Mn in 2019; it is estimated to grow at a CAGR of 5.9% from 2020 to 2027. The growth of the market is attributed to some key driving factors such as increasing number of clinical trials, low cost of conducting a clinical trial compared to western region and increasing government initiatives to conduct clinical trials. However, long timeline for regulatory approval, and lack of personnel participating in clinical research in Middle East are expected to restrain the clinical trial supplies market.

Clinical trial supplies management is necessary for evading overproduction, oversupply, and inventory expiration. With the increasing costs of drug discovery, clinical trial supplies are obtaining more importance. A rise in outsourcing activities by pharmaceutical companies has been witnessed during recent years. The major factors driving the outsourcing activities by companies include cost cutting, need for innovations, increased speed and agility, and access to specialized knowledge and technologies. Hence, with an increase in the R&D expenditure, the need for clinical trial outsourcing is increasing. Furthermore, the collaborative research between the research & development team of the sponsoring company as well as contract developer is a new trend being employed in the market. In addition, the emerging trend of outsourcing has led to rise in development of drug candidates and clinical trials by pharmaceutical and biotechnology companies, which is also expected to account for the growth of the market over the coming years. Also, rising prevalence of chronic diseases such as various cancer types and increasing pharmaceutical and biopharmaceutical R&D expenditures in several developing nations are expected to bolster the demand for clinical trial supplies & services.

Since the surge of COVID-19 cases, the pharmaceutical industry is facing a decrease in production capabilities, resulting in drug shortages. Moreover, diversion of resources from drug development to coronavirus treatment is likely to hamper overall productivity of the drug development for a short period of span. Various pharmaceutical companies made decisions to postpone the ongoing clinical trials due to disrupted supply chains and threat of the virus. The Middle East is struggling to control the crisis due to limited healthcare supplies owing to imposed US sanctions on the country. Such restrictions are likely to have a negative impact on the research and development activities, which will directly restrain the growth of the clinical trial supplies market in the Middle East & Africa.

 

Key Market Segments

Based on product & service, the Middle East and Africa clinical trial supplies market is segmented into manufacturing, packaging & labelling, and logistics & distribution. The logistics & distribution segment held the largest share of the market in 2019; the same segment is anticipated to register the highest CAGR in the market during the forecast period.

In terms of stage, the Middle East and Africa clinical trial supplies market is segmented into phase I, phase II, phase III, and bioequivalence studies. The phase III segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

Based on drug type, the Middle East and Africa clinical trial supplies market is segmented into small-molecule drugs and biologic drugs. The small-molecule drugs segment held the largest share of the market in 2019, whereas the biologic drugs segment is estimated to register the highest CAGR in the market during the forecast period.

 

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Middle East and Africa clinical trial supplies market are the Dubai Health Care City (DHCC), Saudi Clinical Trial Registry (SCTR) and Association of Clinical Research Organizations (ACRO).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of Middle East and Africa clinical trial supplies market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Middle East and Africa clinical trial supplies market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Middle East and Africa clinical trial supplies market.

 

MIDDLE EAST AND AFRICA CLINICAL TRIAL SUPPLIES MARKET SEGMENTATION

By Product & Service

  • Manufacturing
  • Packaging & Labelling
  • Logistics & Distribution

By Stage

  • Phase I
  • Phase II
  • Phase III
  • Bioequivalence Studies

By Drug Type

  • Small-molecule Drugs
  • Biologic Drugs

By Application

  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Respiratory Disorders
  • Others

By Country

  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East and Africa

Company Profiles

  • THERMO FISHER SCIENTIFIC INC.
  • UDG Healthcare plc
  • Catalent Inc.
  • pci Pharma Services
  • PAREXEL INTERNATIONAL CORPORATION
  • Biocair
  • Owens & Minor Inc
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East and Africa Clinical Trial Supplies Market – By Product & Service

1.3.2        Middle East and Africa Clinical Trial Supplies Market – By Stage

1.3.3        Middle East and Africa Clinical Trial Supplies Market – By Drug Type

1.3.4        Middle East and Africa Clinical Trial Supplies Market – By Application

1.3.5        Middle East and Africa Clinical Trial Supplies Market – By Geography

2.           Clinical Trial Supplies Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Clinical Trial Supplies – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Middle East and Africa (MEA) – PEST Analysis

4.3         Expert Opinion

5.           Clinical Trial Supplies – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Pharmaceutical and Biopharmaceutical R&D Expenditures

5.1.2        Higher Cost of Drug Development Process in Developed Countries

5.2         Market Restraints

5.2.1        Rising Cost of Drug Development and Clinical Trials

5.2.2        Challenges for Clinical Trials Due to Negative Impact of Corona Virus

5.3         Key Market Opportunities

5.3.1        Growing Opportunities in Developing Nations

5.4         Future Trends

5.4.1        Growing Biosimilars and Biologics Market

5.5         Impact analysis

6.           Clinical Trial Supplies Market –Middle East and Africa Analysis

6.1         Middle East and Africa Clinical Trial Supplies Market Revenue Forecast and Analysis

7.           Clinical Trial Supplies Market Analysis – By Product and Service

7.1         Overview

7.2         Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

7.3         Logistics & Distribution

7.3.1        Overview

7.3.2        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Manufacturing

7.4.1        Overview

7.4.2        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Packaging & Labelling

7.5.1        Overview

7.5.2        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.           Clinical Trial Supplies Market – By Stage

8.1         Overview

8.2         Clinical Trial Supplies Market, by Stage, 2019 and 2027 (%)

8.3         Phase III

8.3.1        Overview

8.3.2        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Phase II

8.4.1        Overview

8.4.2        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Bioequivalence Studies

8.5.1        Overview

8.5.2        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

8.6         Phase I

8.6.1        Overview

8.6.2        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.           Clinical Trial Supplies Market – By Drug Type

9.1         Overview

9.2         Clinical Trial Supplies Market, by Drug Type 2019 and 2027 (%)

9.3         Small-molecule Drugs

9.3.1        Overview

9.3.2        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

9.4         Biologic Drugs

9.4.1        Overview

9.4.2        Biologic Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.        Clinical Trial Supplies Market – By Application

10.1      Overview

10.2      Clinical Trial Supplies Market, by Application 2019 and 2027 (%)

10.3      Oncology

10.3.1     Overview

10.3.2     Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.4      Cardiovascular Diseases

10.4.1     Overview

10.4.2     Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.5      Neurological Disorders

10.5.1     Overview

10.5.2     Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.6      Respiratory Disorders

10.6.1     Overview

10.6.2     Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

10.7      Others

10.7.1     Overview

10.7.2     Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.        Clinical Trial Supplies Market – Middle East and Africa Analysis

11.1      Middle East & Africa: Clinical Trial Supplies Market

11.1.1     Overview

11.1.2     Middle East & Africa: Clinical Trial Supplies Market Share by Country – 2019 & 2027, (%)

11.1.3     Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.1       Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.3.2       Saudi Arabia: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.3.3       Saudi Arabia: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.3.4       Saudi Arabia: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.3.5       Saudi Arabia: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.4     UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.1       UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.4.2       UAE: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.4.3       UAE: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.4.4       UAE: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.4.5       UAE: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

11.1.5     South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

11.1.5.1       South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

11.1.5.2       South Africa: Clinical Trial Supplies Market, by Product & Service, 2018–2027 (USD Million)

11.1.5.3       South Africa: Clinical Trial Supplies Market, by Stage, 2018–2027 (USD Million)

11.1.5.4       South Africa: Clinical Trial Supplies Market, by Drug Type, 2018–2027 (USD Million)

11.1.5.5       South Africa: Clinical Trial Supplies Market, by Application, 2018–2027 (USD Million)

12.        Impact of COVID-19 Pandemic on Middle East and Africa Clinical Trial Supplies Market

12.1      Middle East and Africa: Impact Assessment of COVID-19 Pandemic

13.        Clinical Trials Supplies Market – Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.        Clinical Trial Supplies Market – Key Company Profiles

14.1      THERMO FISHER SCIENTIFIC INC.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      UDG Healthcare plc

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Catalent Inc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      PAREXEL INTERNATIONAL CORPORATION

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Biocair

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6      Owens & Minor Inc.

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

15.        Appendix

15.1      About the Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.             Saudi Arabia Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027  (USD Million)

Table 2.             Saudi Arabia Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 3.             Saudi Arabia Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Saudi Arabia Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             UAE Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 6.             UAE Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 7.             UAE Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             UAE Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             South Africa Clinical Trial Supplies Market, by Product & Service – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Africa Clinical Trial Supplies Market, by Stage – Revenue and Forecast to 2027 (USD Million)

Table 11.          South Africa Clinical Trial Supplies Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          South Africa Clinical Trial Supplies Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Organic Developments Done by Companies

Table 14.          Inorganic Developments Done by Companies

Table 15.          Glossary of Terms, Clinical Trial Supplies Market

LIST OF FIGURES

Figure 1.           Clinical Trial Supplies Market Segmentation

Figure 2.           Clinical Trial Supplies Segmentation, By Country

Figure 3.           Middle East and Africa Clinical Trial Supplies Market Overview

Figure 4.           Logistics & Distribution Segment Held Largest Share of Product & Service Segment in Clinical Trial Supplies Market

Figure 5.           Phase III Segment Held Largest Share of Stage Segment in Clinical Trial Supplies Market

Figure 6.           Small-molecule Drugs Segment Held Largest Share of Drug type Segment in Clinical Trial Supplies Market

Figure 7.           Oncology Segment Held Largest Share of Application Segment in Clinical Trial Supplies Market

Figure 8.           UAE Is Expected to Show Remarkable Growth During the Forecast Period

Figure 9.           Middle East and Africa (MEA) PEST Analysis

Figure 10.        Clinical Trial Supplies Market Impact Analysis of Drivers and Restraints

Figure 11.        Middle East and Africa Clinical Trial Supplies Market – Revenue Forecast and Analysis – 2019- 2027

Figure 12.        Clinical Trial Supplies Market Revenue Share, by Product and Service (2019 and 2027)

Figure 13.        Logistics & Distribution: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Manufacturing: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Packaging & Labelling: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Clinical Trial Supplies Market, by Stage 2019 and 2027 (%)

Figure 17.        Phase III: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 18.        Phase II: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Bioequivalence Studies: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Phase I: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Clinical Trial Supplies Market, by Drug Type, 2019 and 2027 (%)

Figure 22.        Small-molecule Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Biologics Drugs: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Clinical Trial Supplies Market, by Application, 2019 and 2027 (%)

Figure 25.        Oncology: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Cardiovascular Diseases: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Neurological Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 28.        Respiratory Disorders: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 29.        Others: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 30.        Middle East & Africa: Clinical Trial Supplies Market, by Key Country – Revenue (2019) (USD Million)

Figure 31.        Middle East & Africa: Clinical Trial Supplies Market Share by Country – 2019 & 2027, (%)

Figure 32.        Saudi Arabia: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        UAE: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (US$ Million)

Figure 34.        South Africa: Clinical Trial Supplies Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Impact Of COVID-19 Pandemic in Middle East and Africa

 

  1. THERMO FISHER SCIENTIFIC INC.
  2. UDG Healthcare plc
  3. Catalent Inc.
  4. pci Pharma Services
  5. PAREXEL INTERNATIONAL CORPORATION
  6. Biocair
  7. Owens & Minor Inc

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000